Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasm

Human Pathology

Volumn 46, Issue 2, 2015, Pages 322-326

  Rakheja, Dinesh ^a,b   Fuda, Franklin ^a   Vandergriff, Travis ^a   Boriack, Richard ^b   Medeiros, Bruno C ^c   Frankel, Arthur E ^a   Chen, Weina ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blastic plasmacytoid dendritic cell neoplasm d 2 hydroxyglutarate; Hypermethylation; IDH mutation; Oncometabolite

Indexed keywords

2 HYDROXYGLUTARIC ACID; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; METHOTREXATE; PRALATREXATE; VINCRISTINE; ALPHA-HYDROXYGLUTARATE; GLUTARIC ACID DERIVATIVE; ISOCITRATE DEHYDROGENASE;

AGED; ARTICLE; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; CASE REPORT; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; SKIN BIOPSY; BLOOD; DENDRITIC CELL; GENETICS; HEMATOLOGIC NEOPLASMS; METABOLISM; MUTATION; PATHOLOGY;

AGED; DENDRITIC CELLS; FEMALE; GLUTARATES; HEMATOLOGIC NEOPLASMS; HUMANS; ISOCITRATE DEHYDROGENASE; MUTATION;

EID: 84920890241     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.10.013     Document Type: Article

References (17)

1. F. Facchetti, D. Jones, and T. Petrella Blastic plasmacytoid dendritic cells neoplasm S.H. Swerdlow, E. Campo, E.S. Jaffe, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. 2008 IARC Press Lyon, France 145 147
2. K. Alayed, K.P. Patel, and S. Konoplev TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow Am J Hematol 88 2013 1055 1061
3. J. Menezes, F. Acquadro, and M. Wiseman Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm Leukemia 28 2014 823 829
4. L. Dang, D.W. White, and S. Gross Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 2009 739 744
5. E.R. Mardis, L. Ding, and D.J. Dooling Recurring mutations found by sequencing an acute myeloid leukemia genome N Engl J Med 361 2009 1058 1066
6. H. Yan, D.W. Parsons, and G. Jin IDH1 and IDH2 mutations in gliomas N Engl J Med 360 2009 765 773
7. D. Rakheja, S. Konoplev, and M. Su High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei Br J Haematol 155 2011 125 128
8. B. Pietrak, H. Zhao, and H. Qi A tale of two subunits: how the neomorphic R132H IDH1 mutation enhances production of alphaHG Biochemistry 50 2011 4804 4812
9. C.D. DiNardo, K.J. Propert, and A.W. Loren Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia Blood 121 2013 4917 4924
10. S. Gross, R.A. Cairns, and M.D. Minden Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations J Exp Med 207 2010 339 344
11. D. Rakheja, M. Mitui, R.L. Boriack, and R.J. DeBerardinis Isocitrate dehydrogenase 1/2 mutational analyses and 2-hydroxyglutarate measurements in Wilms tumors Pediatr Blood Cancer 56 2011 379 383
12. D. Rakheja, S. Konoplev, L.J. Medeiros, and W. Chen IDH mutations in acute myeloid leukemia Hum Pathol 43 2012 1541 1551
13. W. Xu, H. Yang, and Y. Liu Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases Cancer Cell 19 2011 17 30
14. M.E. Figueroa, O. Abdel-Wahab, and C. Lu Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 18 2010 553 567
15. R. Bejar, A. Lord, and K. Stevenson TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients Blood 124 2014 2705 2712
16. K. Laribi, N. Denizon, and H. Ghnaya Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-azacytidine Eur J Haematol 93 2014 81 85
17. D.A. Pollyea, H.E. Kohrt, and B. Zhang 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels Leuk Lymphoma 54 2013 408 410